Financial Indicators (TRY)

2024/12

2025/03

Total Assets

96,531,141,651

124,104,094,942

Total Liabilities

67,808,047,211

90,972,646,716

Paid-in Capital

5,000,000,000

5,000,000,000

Shareholder’s Equity

28,723,094,440

33,131,448,226

 

2024/03

2025/03

Premium Production

28,162,729,848

41,401,841,724

 

Gross Claims Paid

-6,910,713,249

-10,283,108,785

 

Operational Expenses

-2,069,125,992

-3,035,775,186

Investment Income

5,572,036,759

6,954,032,633

 

Investment Expenses

-5,352,929,900

-5,769,932,636

Net Investment Income

219,106,859

1,184,099,997

Extraordinary Income Expenses

-614,965,762

-863,968,547

Technical Profit

4,621,183,149

5,320,887,576

Net Profit

3,526,611,681

4,522,972,646

Ratios Regarding Asset Quality & Liquidity

2024/12

2025/03

Cash Ratio

89%

79%

Liquidity Ratio

119%

116%

Current Ratio

131%

128%

Receivables from Premium and Reinsurance / Total Assets

20%

25%

Asset Profitability

15%

17%

Equity Profitability

58%

59%

Operational Ratios

2024/12

2025/03

 Retention Ratio

41%

46%

Claims Paid / (Claims Paid + Outstanding Claims)

21%

20%

Profitability Ratios

2024/03

2025/03

Net Loss/Premium Ratio

70%

76%

 

Net Commission Ratio

12%

12%

 

Net Expense Ratio

9%

11%

Net Compound Ratio

90%

99%